A novel human nicotinic receptor subunit, alpha10, that confers functionality to the alpha9-subunit

Area of Science:

• Neuroscience
• Molecular Biology
• Pharmacology

Background:

• Nicotinic acetylcholine receptors (nAChRs) are ligand-gated ion channels crucial for neurotransmission.
• The alpha9 nAChR subunit is known, but its functional partners and native expression remain incompletely understood.

Purpose of the Study:

• To clone and characterize a novel alpha-like subunit related to the alpha9 nAChR.
• To investigate the functional role of this new subunit in receptor assembly and properties.

Main Methods:

• cDNA cloning of the human alpha9-ortholog and a novel alpha10 subunit.
• Expression studies involving co-injection of alpha9 and alpha10 subunits into oocytes.
• Electrophysiological recordings to measure acetylcholine-evoked currents.
• Construction and analysis of a functional alpha9:alpha10 chimera.
• Analysis of tissue distribution of alpha9 and alpha10 subunit mRNAs.

Main Results:

• Identification and cloning of a novel alpha10 nAChR subunit sharing 58% identity with alpha9.
• Alpha10 alone does not form functional receptors, but co-expression with alpha9 yields robust acetylcholine-evoked currents.
• Co-assembly of alpha9 and alpha10 subunits modifies the physiological and pharmacological characteristics of the resulting receptor.
• A functional chimera demonstrated distinct binding (alpha9) and pore (alpha10) properties.
• Alpha9 and alpha10 subunit mRNAs exhibit overlapping expression in the cochlea, pituitary gland, and keratinocytes.

Conclusions:

• A novel alpha10 nAChR subunit has been identified and characterized.
• The alpha10 subunit co-assembles with the alpha9 subunit to form a functional nAChR.
• This novel alpha9/alpha10 receptor subtype likely plays a role in tissues such as the cochlea.